Xiao Han (Nicole)
About Xiao Han (Nicole)
Xiao Han (Nicole) is an Associate IP Counsel at BeiGene with extensive experience in patent law, particularly in biotechnology, pharmaceutics, and chemistry.
Current Role at BeiGene
Nicole Xiao Han currently holds the position of Associate IP Counsel at BeiGene. Since July 2022, she has been contributing to the company's intellectual property strategies and legal frameworks. Her role involves managing patent portfolios, ensuring compliance with regulatory requirements, and supporting the biotech company's innovation initiatives.
Previous Experience at Foundin IP
Before joining BeiGene, Xiao Han worked at Foundin IP in Beijing, China, where she served as a Patent Attorney and Attorney at Law from 2021 to 2022. In this role, she handled various aspects of patent law, focusing on international patent prosecution and litigation, particularly in the biotechnology, pharmaceutics, and chemistry sectors.
Work at Chofn Intellectual Property
From 2019 to 2022, Xiao Han was an integral part of Chofn Intellectual Property, a leading IP services firm in Beijing. As a Patent Attorney and Attorney at Law, she was responsible for the prosecution and consultation of patents, leveraging her specialized knowledge in biotechnology, pharmaceutics, and chemistry.
Experience as Patent Specialist
Xiao Han also contributed to the field of intellectual property while working as a Patent Specialist at Matthias Scholl, Inc. in Shenzhen, Guangdong, China, from 2016 to 2019. During her tenure, she focused on patent engineering tasks, including drafting and filing patent applications, ensuring the protection of intellectual property in various jurisdictions.
Educational Background
Nicole Xiao Han's educational journey includes a Master's Degree in Pharmaceutics and Drug Design from UCL, obtained in 2015. Prior to that, she earned a Bachelor's Degree in Biochemistry and Molecular Biology from the University of St Andrews in 2014. Her academic background has provided her with a solid foundation in the sciences, enhancing her capacity to navigate complex patent matters in the fields of biotechnology and pharmaceutics.